An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers "BRONCE-AP"

Completed

Phase 4 Results N/A

Main Contacts

Name Phone E-mail
Bayer Study Director Study Director
Bayer Clinical Trials Contact Contact clinical-trials-contact@bayerhealthcare.com

Other Locations

Name City State Country Status
Name Unavailable Many Locations Spain Unknown_status_icon